Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis M Domenicali, M Baldassarre, FA Giannone, M Naldi, M Mastroroberto, ... Hepatology 60 (6), 1851-1860, 2014 | 184 | 2014 |
Kinetic characterization of amyloid-beta 1–42 aggregation with a multimethodological approach M Bartolini, M Naldi, J Fiori, F Valle, F Biscarini, DV Nicolau, V Andrisano Analytical biochemistry 414 (2), 215-225, 2011 | 139 | 2011 |
Amyloid β-peptide 25–35 self-assembly and its inhibition: A model undecapeptide system to gain atomistic and secondary structure details of the Alzheimer’s disease process and … M Naldi, J Fiori, M Pistolozzi, AF Drake, C Bertucci, R Wu, K Mlynarczyk, ... ACS chemical neuroscience 3 (11), 952-962, 2012 | 112 | 2012 |
Bright oligothiophene N-succinimidyl esters for efficient fluorescent labeling of proteins and oligonucleotides G Barbarella, M Zambianchi, A Ventola, E Fabiano, F Della Sala, G Gigli, ... Bioconjugate chemistry 17 (1), 58-67, 2006 | 76 | 2006 |
Determination of effective albumin in patients with decompensated cirrhosis: clinical and prognostic implications M Baldassarre, M Naldi, G Zaccherini, M Bartoletti, A Antognoli, ... Hepatology 74 (4), 2058-2073, 2021 | 75 | 2021 |
UHPLC determination of catechins for the quality control of green tea M Naldi, J Fiori, R Gotti, A Périat, JL Veuthey, D Guillarme, V Andrisano Journal of pharmaceutical and biomedical analysis 88, 307-314, 2014 | 74 | 2014 |
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors F Mancini, M Naldi, V Cavrini, V Andrisano Analytical and bioanalytical chemistry 388, 1175-1183, 2007 | 74 | 2007 |
Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3 K Oukoloff, N Coquelle, M Bartolini, M Naldi, R Le Guevel, S Bach, ... European journal of medicinal chemistry 168, 58-77, 2019 | 66 | 2019 |
Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis M Naldi, M Baldassarre, M Domenicali, M Bartolini, P Caraceni Journal of pharmaceutical and biomedical analysis 144, 138-153, 2017 | 66 | 2017 |
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis M Naldi, U Černigoj, A Štrancar, M Bartolini Talanta 167, 143-157, 2017 | 62 | 2017 |
Dual-acting cholinesterase–human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo M Scheiner, D Dolles, S Gunesch, M Hoffmann, M Nabissi, O Marinelli, ... Journal of medicinal chemistry 62 (20), 9078-9102, 2019 | 54 | 2019 |
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment S Montanari, AM Mahmoud, L Pruccoli, A Rabbito, M Naldi, S Petralla, ... European Journal of Medicinal Chemistry 178, 243-258, 2019 | 54 | 2019 |
Development and characterization of β-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies F Mancini, M Naldi, V Cavrini, V Andrisano Journal of Chromatography A 1175 (2), 217-226, 2007 | 51 | 2007 |
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases M Naldi, M Baldassarre, M Nati, M Laggetta, FA Giannone, M Domenicali, ... Journal of Pharmaceutical and Biomedical Analysis 112, 169-175, 2015 | 50 | 2015 |
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 V Andrisano, M Naldi, A De Simone, M Bartolini Expert opinion on therapeutic patents 28 (6), 455-465, 2018 | 43 | 2018 |
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer C Parolin, N Calonghi, E Presta, C Boga, P Caruana, M Naldi, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2012 | 43 | 2012 |
Discovery and in vivo proof of concept of a highly potent dual inhibitor of soluble epoxide hydrolase and acetylcholinesterase for the treatment of Alzheimer’s disease S Codony, C Pont, C Griñán-Ferré, A Di Pede-Mattatelli, C Calvó-Tusell, ... Journal of Medicinal Chemistry 65 (6), 4909-4925, 2022 | 42 | 2022 |
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule M Baldassarre, M Domenicali, M Naldi, M Laggetta, FA Giannone, ... Scientific Reports 6 (1), 35987, 2016 | 42 | 2016 |
Immobilized enzyme reactors: an overview of applications in drug discovery from 2008 to 2018 A De Simone, M Naldi, M Bartolini, L Davani, V Andrisano Chromatographia 82, 425-441, 2019 | 39 | 2019 |
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry M Naldi, V Andrisano, J Fiori, N Calonghi, E Pagnotta, C Parolin, ... Journal of Chromatography A 1129 (1), 73-81, 2006 | 38 | 2006 |